• Profile
Close

Acute hypocalcaemia following denosumab in heart and lung transplant patients with osteoporosis

Internal Medicine Journal Jun 23, 2018

Shrosbree JE, et al. - The risk of hypocalcaemia in a heart and lung transplant cohort prescribed denosumab for osteoporosis was investigated in this analysis. A retrospective database review was performed of all surviving heart and lung transplant patients who received denosumab between January 2012 and November 2015 for osteoporosis. The findings from the present study showed that half of the patients prescribed denosumab developed some level of hypocalcemia. Researchers suggested that denosumab should be used cautiously in patients with advanced renal disease due to the risk of hypocalcaemia in heart and lung transplant patients.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay